
Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPWGNhU3pjS0lJMVBlckZlSWh4djlqS2c5b285R3JsVVJ6T1ktSFBfaXRYWUU3UDBzWEt1VHNJZWlCWE04TnBFMUpyNVNIemxvNXFwQzZRazU2TWhFWHl5bmVIWi1HMVp6ZWtMLWJmVGNuZk14Q3RWUDBPenhuakpqUTNBZmxxRklYOHk0?oc=5" target="_blank">Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials</a>&nbsp;&nbsp;<font color="#6f6f6f">The Lancet</font>
